Dealing with Reality: Using Regulatory and Biostatistics Strategies to Adapt to the Unexpected in Clinical Trials
Join Veramed’s Debra Anderson, SVP, Strategic Partnerships, Mark Holland, Head of Programming Delivery, and Facet Life Science’s Lisa Jenkins VanLuvanee, COO & VP, R&D and Jason Mercer, Regulatory Affairs Consultant, to discover actionable insights to help you respond to unexpected challenges in clinical trials with confidence. Agenda Highlights:
Planning for Success: Unlock Regulatory & Biometric Strategies for Clinical Trials
Join Veramed’s Debra Anderson, SVP, Strategic Partnerships, Mark Holland, Head of Programming Delivery, and Facet Life Science’s Lisa Jenkins VanLuvanee, COO & VP, R&D and Jason Mercer, Regulatory Affairs Consultant, for an insightful webinar exploring the critical role of integrated regulatory and statistical planning in clinical trial success. Agenda Highlights:
Weather, Elections and Clinical Trials: Some Novel Approaches to Visualizing Uncertainty
This animation is known as a Hypothetical Outcome Plot (HOP) which can be effective in communicating inferential uncertainty to an audience without statistical training. Such novel data visualization methods are common in fields such as election forecasting and hurricane prediction, but quite underutilised in clinical trial reporting. Weather, Elections and Clinical Trials: Some novel approaches […]
Digital Technologies in Clinical Trials: Just-in-time Adaptive Interventions, Dynamic Treatment Regimes, and Missing Data in Digital Outcomes
In this webinar, Dr Lauren Bell outlines the development of a just-in-time behavioral interventions, Gwen Perry describes how we can ask detailed questions on behavioral/medication treatment sequences with SMART trials, and Cambridge University’s Dr Mia Tackney describes how to handle missing data in trials with digital endpoints.
Pragmatic Trials 101: Trial Benefits, Application, and Key Considerations for Decision-Makers and Statisticians
In this webinar, Rachel Tham, Principal Statistician at Veramed, and Thomas Kumke, SSI RWE Strategy Lead at UCB, will explore certain tools for pragmatic trials and their application before jumping into Cluster Randomized Trials, considerations to keep in mind, and their benefits with a unique ability to naturally account for herd immunity in vaccine studies. […]
From PICO to Estimand: Navigating the Maze of Evidence Generation in EU HTA
In this webinar, Marius Sieverding, Data Scientist, Veramed shares his insights on how best to collaborate in an evolving submission landscape from a Statistical and Clinical perspective. During the Q&A session, Marius is joined by Arthur Allignol, Senior Principal Statistician, Daiichi Sankyo, a member of the PSI HTA special interest group, who provides a unique […]
A Statistical Perspective on Externally Controlled Trials
Join Amy Mulick, Head of Evidence & Value Generation at Veramed, and Christen Gray, Director, Real World Science for Vaccines & Immune Therapies at AstraZeneca, as they share their RWD expertise and how best to approach analyses with external comparators, with insight from a Statistical perspective. Agenda
Data Visualizations: Tips to Connect with your Audience and Deliver Powerful Insight
Join Francesca Pannullo, Senior Statistician at Veramed, and our expert team as they share vital tips and insight, using case studies and examples through the R Shiny App, to give you the right tools and know-how to take your Data Visualizations to the next step. Agenda
Data Visualization Webinars
With tightening margins and deadlines facing today’s clinical trial journeys, the need to communicate and share data through powerful visualizations is paramount. Watch our latest Data Visualization Webinar to discover the future of data visualization in the bio-pharma space and how to tackle common industry challenges. April, 2023 Data Visualizations: tips to connect with your […]
Statistical Challenges in Immuno-Oncology Trials: How to Think Outside the box and Increase Efficiency
Join Toby Batten, Statistics Manager at Veramed and our special guest co-host, Carlo Lanza, as they discuss the evolution, challenges and road ahead of Clinical Oncology – focusing on Phase I, II and III specifically. Carlo and Toby will share how to think outside the box from a clinical and statistical point of view, address […]